Biopharmaceutical drug delivery company Halozyme Therapeutics (NASDAQ:HALO) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 22.1% year on year to $354.3 million.

Another Halo: Reach weapon, the Grenade Launcher is notable for its dual modes, where holding the trigger allows it to ...

Cameron was first romantically linked to the Måneskin singer in September 2023, nearly one year before they made their red ...

Jaguar is reinventing itself. What if the next-gen F-Pace adopted the bold design language of the Type 00 concept? Here’s how ...

The Ram TRX is officially back, and it’s returning with more power, more tech, and a renewed SRT badge to shake up the ...

Two NASA heliophysics missions launched together in September are performing well, while a third mission launched earlier ...

A new computational breakthrough is giving scientists a clearer view into how dark matter structures evolve. Dark matter has ...

Automakers cancel cars all the time. After all, they're in the business of turning a profit, and the line's always got to go ...

The original Xbox console first released on November 15th of 2001, which means that exact date in 2026 marks the 25th ...

Not for distribution to U.S. newswire services or dissemination in the United States TORONTO, (GLOBE NEWSWIRE) -- Galantas Gold ...

Three planets shine in 2026 along with two lunar eclipses, one solar eclipse, and a summer meteor shower. Here’s what's up in ...

On Jan. 15, 2025, the Gaia spacecraft took its last image. Then the craft ran a final round of engineering tests, fired its ...